ARTICLE SUMMARY:
The arrhythmia monitoring market is undergoing a digital health-driven transformation, and the implications for the wider medtech industry could be substantial. In Part 2 of this two-part article, we discuss the competitive landscape in arrhythmia monitoring, the unmet needs driving tech-enabled solutions, and what the future could hold for this space.
Much has been said about the potential impact of digital health, artificial intelligence (AI), and other high-tech advances on the patient care paradigm, and some clinical spaces—diabetes is perhaps the best example—have already widely embraced a more high-tech, connected, and patient-centered care model. ( See “Diabetes Devices: A Market in Transition,” MedTech Strategist, October 12, 2017.)
